Intracerebroventricular B7-H3-targeting CAR T cells for non-pontine DMG and recurrent/refractory pediatric CNS tumors: a phase 1 trial

Neuro-Oncology · Published 2026-07-25 · DOI 10.1093/neuonc/noag171

Authors (36)

Rebecca Ronsley, Wenjun Huang, Ethan Rohlf, Kristy Seidel, Christopher Brown, Adam Beebe, Stephanie D Rawlings-Rhea, Catherine Lindgren, Tiffany Sad, Erin E Crotty, Sarah E S Leary, Alison Thomsen, Amy R Beckstrom, Susan L Holtzclaw, Corrine Hoeppner, Diana Hurst, Matthew MacQuivey, Hannah E Goldstein, Samuel R Browd, Jason S Hauptman, Amy Lee, Jeffrey G Ojemann, Jason N Wright, Catherine M Albert, Navin Pinto, Joshua A Gustafson, On Ho, Sowmya Pattabhi, Corinne Summers, Colleen Annesley, Jason N Wendler, Juliane Gust, Rebecca A Gardner, Julie R Park, Michael C Jensen, Nicholas A. Vitanza

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Ronsley, R., Huang, W., Rohlf, E., et al. (2026). Intracerebroventricular B7-H3-targeting CAR T cells for non-pontine DMG and recurrent/refractory pediatric CNS tumors: a phase 1 trial. Neuro-Oncology. https://doi.org/10.1093/neuonc/noag171

Related articles